Please provide your email address to receive an email when new articles are posted on . A study comparing measurements taken by time domain and spectral domain optical coherence tomography ...
Hosted on MSN
Zeiss’ AI-driven tool gets CE mark for OCT scans
Zeiss Medical Technology has received CE mark approval for its CIRRUS PathFinder, a clinical support tool that utilises AI to assist in the interpretation of optical coherence tomography (OCT) scans.
Please provide your email address to receive an email when new articles are posted on . Jim Taylor, president and CEO of Carl Zeiss Meditec, spoke with OSN about the company's planned purchase of LDT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results